The amount of ionizing radiation conferred by an ordinary chest x-ray significantly increases the already high risk of breast cancer in young women with BRCA1/2 germline mutations, according to a recent international retrospective cohort study.
The amount of ionizing radiation conferred by an ordinary chest x-ray significantly increases the already high risk of breast cancer in young women with BRCA1/2 germline mutations, according to a recent international retrospective cohort study.
Researchers from Europe and Canada included 1,600 female BRCA1/2 carriers in their study. They found that any exposure to chest x-rays was associated with an increased risk of breast cancer (HR=1.54; 95% CI; 1.1–2.1). They also calculated that the risk was almost doubled in carrier women 40 years of age and younger (HR=1.97; 95% CI; 1.3–2.9).
The study is particularly significant because the dose of radiation studied is at least an order of magnitude lower than that in other radiation-exposed cohorts studied to date. It is possible that loss of normal BRCA1- or BRCA2-associated DNA repair activity may predispose women who carry mutations in these genes to accumulate radiation-induced genetic damage that accelerates carcinogenesis.
Commentary by Andrew Berchuck, MD, Director of Gynecologic Oncology, Duke University Medical Center, Durham, N.C.:
As the study authors noted, it's possible that the findings of this report could be spurious due to recall bias: Women with breast cancer are more likely to remember radiation exposure than those without cancer. In view of the above issue and other potential pitfalls of retrospective studies, these results need to be confirmed in prospective studies.
Ultrasound to predict placental pathology
July 5th 2021Despite the umbilical artery (UA) Doppler pulsatility index being used to detect elevated fetoplacental vascular resistance, the metric is confounded by variation in fetal cardiac function and is only moderately predictive of placental pathology.
Read More
Ultrasound vs. MRI to detect uterine leiomyomas
October 23rd 2020A prospective observational study in the Journal of Ultrasound in Medicine has concluded that for pretreatment evaluation of uterine fibroids (UF), transabdominal contrast-enhanced ultrasound (CEUS) represents a viable alternative to traditional contrast-enhanced magnetic resonance imaging (MRI).
Read More